Colorectal Cancer - Global Market Outlook (2017-2026)

August 2019 | 137 pages | ID: C07840F83BFEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Colorectal Cancer Market is accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion by 2026 growing at a CAGR of 3.9% during the forecast period. Introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations are some of the factors fuelling the market growth. However, factors such as the reluctance toward colorectal cancer medications on the part of patients and a lack of awareness in many parts of the world will pose a threat to the growth of the overall market.

Colorectal cancer (CRC) is one of the “big four” tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together. CRC is believed to arise as a result of interactions between inherited and environmental factors. Despite improved prognosis of CRC patients in the last decade following advances in treatment options, survival rates still lag behind those of breast and prostate cancer patients.

Based on therapies & drugs, the increasing awareness for treating colorectal cancer by chemotherapy and immunotherapy propels the industry growth during the forecast period. By Geography, North America is a key region in the market and estimated to have a lucrative growth in terms of demand and revenue. This market is fueled by a number of factors, the primary one being greater prevalence of colorectal cancer.

Some of the key players profiled in the Colorectal Cancer market include Abbott Laboratories, Amgen Inc., Clinical Genomics, EDP Biotech, Epigenomics AG, Hoffmann-La Roche AG, Novigenix SA, Quest Diagnostics, Sanofi SA, Siemens Healthineers and VolitionRX.

Therapies & Drugs Covered:

• Chemo Therapy
• Immuno Therapy
• Radiation Therapy
• Surgery
• Others Therapies & Drugs

Testing & Diagnosis Covered:

• Immunochemistry
• Macroscopy
• Microscopy
• Staging
• Tumor Budding

Procedures Covered:

• Biopsy
• Colostomy
• Magnetic Resonance Imaging (MRI)
• Mammography
• Sigmoidoscopy

Products Covered:

• Flow Cytometry
• In Situ Hybridization
• Microarrays
• Next-Generation Sequencing
• Targeted Therapy

Applications Covered:

• Hospitals and Clinics
• Other Applications

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• Italy
• France
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• South Korea
• Rest of Asia Pacific
• South America
• Argentina
• Brazil
• Chile
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Qatar
• South Africa
• Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country level segments
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
• Comprehensive profiling of additional market players (up to 3)
• SWOT Analysis of key players (up to 3)
• Regional Segmentation
• Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
• Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL COLORECTAL CANCER MARKET, BY THERAPIES & DRUGS

5.1 Introduction
5.2 Chemo Therapy
  5.2.1 Alkylating Agent - Oxaliplatin (Eloxatin)
  5.2.2 Antimetabolites
    5.2.2.1 Capecitabine (Xeloda)
    5.2.2.2 Fluorouracil (Adrucil)
5.3 Immuno Therapy
  5.3.1 Biologic Response Modifiers
  5.3.2 Colony-Stimulating Factors
  5.3.3 Monoclonal Antibodies
    5.3.3.1 Bevacizumab (Avastin)
    5.3.3.2 Cetuximab (Erbitux)
    5.3.3.3 Panitumumab (Vectibix)
  5.3.4 Tumor Vaccines
5.4 Radiation Therapy
5.5 Surgery
5.6 Others Therapies & Drugs

6 GLOBAL COLORECTAL CANCER MARKET, BY TESTING & DIAGNOSIS

6.1 Introduction
6.2 Immunochemistry
6.3 Macroscopy
6.4 Microscopy
6.5 Staging
6.6 Tumor Budding

7 GLOBAL COLORECTAL CANCER MARKET, BY PROCEDURE

7.1 Introduction
7.2 Biopsy
7.3 Colostomy
7.4 Magnetic Resonance Imaging (MRI)
7.5 Mammography
7.6 Sigmoidoscopy

8 GLOBAL COLORECTAL CANCER MARKET, BY PRODUCT

8.1 Introduction
8.2 Flow Cytometry
8.3 In Situ Hybridization
8.4 Microarrays
8.5 Next-Generation Sequencing
8.6 Targeted Therapy

9 GLOBAL COLORECTAL CANCER MARKET, BY APPLICATION

9.1 Introduction
9.2 Hospitals and Clinics
9.3 Other Applications

10 GLOBAL COLORECTAL CANCER MARKET, BY GEOGRAPHY

10.1 Introduction
10.2 North America
  10.2.1 US
  10.2.2 Canada
  10.2.3 Mexico
10.3 Europe
  10.3.1 Germany
  10.3.2 UK
  10.3.3 Italy
  10.3.4 France
  10.3.5 Spain
  10.3.6 Rest of Europe
10.4 Asia Pacific
  10.4.1 Japan
  10.4.2 China
  10.4.3 India
  10.4.4 Australia
  10.4.5 New Zealand
  10.4.6 South Korea
  10.4.7 Rest of Asia Pacific
10.5 South America
  10.5.1 Argentina
  10.5.2 Brazil
  10.5.3 Chile
  10.5.4 Rest of South America
10.6 Middle East & Africa
  10.6.1 Saudi Arabia
  10.6.2 UAE
  10.6.3 Qatar
  10.6.4 South Africa
  10.6.5 Rest of Middle East & Africa

11 KEY DEVELOPMENTS

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 COMPANY PROFILING

12.1 Abbott Laboratories
12.2 Amgen Inc.
12.3 Clinical Genomics
12.4 EDP Biotech
12.5 Epigenomics AG
12.6 Hoffmann-La Roche AG
12.7 Novigenix SA
12.8 Quest Diagnostics
12.9 Sanofi SA
12.10 Siemens Healthineers
12.11 VolitionRX

List Of Tables

LIST OF TABLES

1 Global Colorectal Cancer Market Outlook, By Region (2016-2026) ($MN)
2 Global Colorectal Cancer Market Outlook, By Therapies & Drugs (2016-2026) ($MN)
3 Global Colorectal Cancer Market Outlook, By Chemo Therapy (2016-2026) ($MN)
4 Global Colorectal Cancer Market Outlook, By Alkylating Agent - Oxaliplatin (Eloxatin) (2016-2026) ($MN)
5 Global Colorectal Cancer Market Outlook, By Antimetabolites (2016-2026) ($MN)
6 Global Colorectal Cancer Market Outlook, By Immuno Therapy (2016-2026) ($MN)
7 Global Colorectal Cancer Market Outlook, By Biologic Response Modifiers (2016-2026) ($MN)
8 Global Colorectal Cancer Market Outlook, By Colony-Stimulating Factors (2016-2026) ($MN)
9 Global Colorectal Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
10 Global Colorectal Cancer Market Outlook, By Tumor Vaccines (2016-2026) ($MN)
11 Global Colorectal Cancer Market Outlook, By Radiation Therapy (2016-2026) ($MN)
12 Global Colorectal Cancer Market Outlook, By Surgery (2016-2026) ($MN)
13 Global Colorectal Cancer Market Outlook, By Others Therapies & Drugs (2016-2026) ($MN)
14 Global Colorectal Cancer Market Outlook, By Testing & Diagnosis (2016-2026) ($MN)
15 Global Colorectal Cancer Market Outlook, By Immunochemistry (2016-2026) ($MN)
16 Global Colorectal Cancer Market Outlook, By Macroscopy (2016-2026) ($MN)
17 Global Colorectal Cancer Market Outlook, By Microscopy (2016-2026) ($MN)
18 Global Colorectal Cancer Market Outlook, By Staging (2016-2026) ($MN)
19 Global Colorectal Cancer Market Outlook, By Tumor Budding (2016-2026) ($MN)
20 Global Colorectal Cancer Market Outlook, By Procedure (2016-2026) ($MN)
21 Global Colorectal Cancer Market Outlook, By Biopsy (2016-2026) ($MN)
22 Global Colorectal Cancer Market Outlook, By Colostomy (2016-2026) ($MN)
23 Global Colorectal Cancer Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
24 Global Colorectal Cancer Market Outlook, By Mammography (2016-2026) ($MN)
25 Global Colorectal Cancer Market Outlook, By Sigmoidoscopy (2016-2026) ($MN)
26 Global Colorectal Cancer Market Outlook, By Product (2016-2026) ($MN)
27 Global Colorectal Cancer Market Outlook, By Flow Cytometry (2016-2026) ($MN)
28 Global Colorectal Cancer Market Outlook, By In Situ Hybridization (2016-2026) ($MN)
29 Global Colorectal Cancer Market Outlook, By Microarrays (2016-2026) ($MN)
30 Global Colorectal Cancer Market Outlook, By Next-Generation Sequencing (2016-2026) ($MN)
31 Global Colorectal Cancer Market Outlook, By Targeted Therapy (2016-2026) ($MN)
32 Global Colorectal Cancer Market Outlook, By Application (2016-2026) ($MN)
33 Global Colorectal Cancer Market Outlook, By Hospitals and Clinics (2016-2026) ($MN)
34 Global Colorectal Cancer Market Outlook, By Other Applications (2016-2026) ($MN)
NOTE: The tables for North America, Europe, APAC, Middle East, Latin America, and Rest of the World Regions are also represented in the same manner as above.